ClinicalTrials.gg
CompletedNCT07904221Updated Oct 29, 2026

Evaluation of the Antibacterial Effect of Probiotics on Cariogenic Bacteria in Children

An interventional study of Probiotic lozenges containing Streptococcus salivarius, Lactobacillus reuteri, and Lactobacillus paracasei and Xylitol-based moisturizing lozenges in Dental Caries in Children, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Ain Shams University · Not applicable, Interventional, and Prevention

Updated Oct 29, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 17 studies in Dental Caries by Ain Shams University — 5 open to participants now, 7 under way, none of them phase 3. Dental Caries · Ain Shams University.

Enrollment
6th of 15
60 · median 40
Started
2026
the only one that year
No phase
12 of 17
5 open now
Registered
14th of 17
by date

Among the 17 studies in Dental Caries by Ain Shams University, this one is the 6th largest by enrollment of the 15 interventional ones, is the only one that started in 2026, is one of 12 with no phase, and was the 14th registered.

By phase

17 studies; the count open now beside each. This study's row is marked.

No phasethis study12 · 5 open
Observational2 · 0 open
Phase 42 · 0 open
Phase 31 · 0 open

By the year they started

First in 2018; this study’s year is marked. 1 started in 2026.

Size and results

Median enrollment 40 across the 15 interventional studies, 276 across the 2 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 17 studies in Dental Caries by Ain Shams University, or all of them as a file.
02

Study summary

This randomized controlled clinical trial aims to evaluate the effect of oral probiotic lozenges containing Streptococcus salivarius, Lactobacillus reuteri, and Lactobacillus paracasei on cariogenic bacteria (Streptococcus mutans, Lactobacillus acidophilus) , salivary pH, buffering capacity, and plaque accumulation in children aged 6-12 years at high caries risk. Sixty children will be assigned into three groups: probiotic, positive control (xylitol lozenges), and negative control (no lozenges). Salivary and plaque parameters will be assessed before and after a 4-week intervention period.

Read the detailed description

I. Abstract

Statement of the problem:

Tooth decay is a common problem among children that significantly affects their oral health. Traditional preventive measures have achieved limited success. Therefore, this study aims to explore the potential of probiotic lozenges to improve oral health by reducing harmful bacteria and enhancing saliva properties, providing a new preventive approach.

The aim of this study is to:

    1. Evaluate the antibacterial effect of oral probiotics lozenges containing Streptococcus salivarius, Lactobacillus reuteri, and Lactobacillus paracasei on the levels of cariogenic bacteria including Streptococcus mutans and Lactobacillus acidophilus in 6-12 year old children.

2) Evaluate the effect of the same type of probiotics lozenges on the salivary pH and buffering capacity of the saliva in 6-12 year old children.

3) Evaluate the effect of the same type of probiotics lozenges on plaque accumulation in 6-12 year old children.

Materials and methods:

  1. This is a single -blinded randomized controlled clinical trial that will involve children aged 6 to 12 years. Participants will be randomly selected, and their caries risk assessment (CAMBRA) will be evaluated for choosing 60 children with high caries risk.
  2. plaque accumulation will be measured using Oral Hygiene Index Simplified.
  3. Unstimulated pre-salivary samples will be collected.
  4. The salivary sample will be analyzed for the levels of Streptococcus mutans, Lactobacillus acidophilus, salivary pH, and buffering capacity.
  5. The children will be divided into three groups: an experimental group and two control groups. The experimental group will be provided with oral probiotic lozenges containing Streptococcus salivarius, Lactobacillus reuteri, and Lactobacillus paracasei for daily consumption once a day at home over a period of four weeks. The first control group will receive xylitol-based moisturizing lozenges as a positive control once a day, while the second control group will serve as a negative control, receiving no lozenges. All groups will be instructed to maintain standardized oral hygiene practices, and will be provided with fluoridated toothpaste and toothbrushes.
  6. After four weeks, plaque accumulation will be remeasured using Oral Hygiene Index Simplified.
  7. post-salivary samples will be collected and analyzed for the same parameters, including the levels of Streptococcus mutans, Lactobacillus acidophilus, salivary pH, and buffering capacity.
03

Conditions studied

  • Dental Caries in Children

Browse trials for

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. 6-12-year-old children.
  2. High caries risk patient according to caries risk assessment (CAMBRA).

Exclusion criteria

Exclusion Criteria:

  1. Patients or parents who refuse to participate.
  2. Children who have received antibiotics or in the previous 48 hours before being recruited.
  3. Children with mental and physical disabilities.
  4. Orphaned children.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Probiotic Lozenges Group

    Participants will receive oral probiotic lozenges containing Streptococcus salivarius, Lactobacillus reuteri, and Lactobacillus paracasei. Lozenges will be administered once daily at home for 4 weeks.

    Dietary Supplement: Probiotic lozenges containing Streptococcus salivarius, Lactobacillus reuteri, and Lactobacillus paracasei

  • Active comparator
    Xylitol Lozenges Group

    Participants will receive xylitol-based moisturizing lozenges once daily at home for 4 weeks.

    Dietary Supplement: Xylitol-based moisturizing lozenges

  • No intervention
    No Lozenges Group

    Participants will not receive any lozenges but will follow standardized oral hygiene practices during the 4-week period.

Interventions

  • Dietary supplementProbiotic lozenges containing Streptococcus salivarius, Lactobacillus reuteri, and Lactobacillus paracasei

    Participants in this group will receive oral probiotics lozenge for daily consumption for 28 days ,once a day (probiotic containing mainly Streptococcus salivarius, Lactobacillus reuteri, and Lactobacillus paracasei). Participants will be instructed to maintain standard oral hygiene practices using fluoridated toothpaste.

    Also known as: SUPERTEETH DENTAL PROBIOTIC

  • Dietary supplementXylitol-based moisturizing lozenges

    Participants in this group will receive one xylitol-based moisturizing lozenge daily for four weeks. The lozenge is to be taken once a day at home. Participants will follow the same oral hygiene instructions as the other groups.

    Also known as: XyliDENT

06

What researchers measure

Primary outcomes

  1. Salivary load of Streptococcus mutans

    Change in salivary Streptococcus mutans load from baseline to 4 weeks after the intervention, measured using quantitative real-time polymerase chain reaction (qRT-PCR).

    Time frame: Baseline and 4 weeks after intervention

  2. Salivary load of Lactobacillus acidophilus

    Change in salivary Lactobacillus acidophilus load from baseline to 4 weeks after the intervention, measured using quantitative real-time polymerase chain reaction (qRT-PCR).

    Time frame: Baseline and 4 weeks after intervention

Secondary outcomes

  1. Clinical evaluation of plaque accumulation using Oral Hygiene Index Simplified

    Change in the total Oral Hygiene Index-Simplified (OHI-S) score from baseline to 4 weeks after the intervention. The total score is calculated as the sum of the Simplified Debris Index (DI-S) and the Simplified Calculus Index (CI-S), ranging from 0 to 6.

    Time frame: Baseline and 4 weeks after intervention

  2. Evaluation of Salivary pH.

    Change in salivary pH from baseline to 4 weeks after the intervention, measured using a calibrated digital pH meter.

    Time frame: Baseline and 4 weeks after intervention

  3. Evaluation of Buffering capacity

    Change in salivary buffering capacity from baseline to 4 weeks after the intervention, assessed using the acid-titration method.

    Time frame: Baseline and 4 weeks after intervention

07

Study locations

1 site
  • Faculty of Dentistry, Ain Shams University
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2026 to primary completion in Oct 2026, 1 month.

Of 469 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's 1 month is below that.

Counting every sponsor, half of 502 studies reached it within 15 months; a quarter within 7 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 29, 2025
First posted
Oct 29, 2026
StartActual
Sep 1, 2026
Primary completionActual
Oct 15, 2026
CompletionActual
Oct 15, 2026
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07904221
Responsible party
Sally Bashar Fahd (Master's Student, Ain Shams University) — Principal investigator
First posted
Oct 29, 2026
Start date
Sep 1, 2026
Primary completion
Oct 15, 2026
Completion
Oct 15, 2026
Last update
Oct 29, 2026

Study contacts

Nour Wahba
study chair · Ain Shams University - Faculty of Dentistry

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion